McKesson (MCK)

• Market cap: $78.6B
• 1 day: -0.63%
• 5 days: -2.08%
• 1 month: 18.03%
• 3 months: 11.16%
• 6 months: 9.92%
• Year to date: 28.07%
• 1 year: 35.82%
• 5 years: 308.77%
• 10 years: 196.65%
• Sector: Healthcare
• Industry: Drugs, Proprietaries & Druggists Sundries

About: McKesson Corp is one of three leading pharmaceutical wholesalers in the us engaged in sourcing and distributing branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with Cencora and Cardinal Health, the three account for over 90% of the us pharmaceutical wholesale industry. Outside the us market, McKesson engages in pharmaceutical wholesale and distribution in Canada. Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.

Employees: 51,000

Fund manager confidence

Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)

60% more call options, than puts

Call options by funds: $980M | Put options by funds: $612M

4.33% less ownership

Funds ownership: 88.05% [Q2] → 83.72% (-4.33%) [Q3]

7% less funds holding

Funds holding: 1,600 [Q2] → 1,485 (-115) [Q3]

20% less capital invested

Capital invested by funds: $66.6B [Q2] → $53.2B (-$13.4B) [Q3]

22% less repeat investments, than reductions

Existing positions increased: 494 | Existing positions reduced: 635

27% less funds holding in top 10

Funds holding in top 10: 45 [Q2] → 33 (-12) [Q3]

52% less first-time investments, than exits

New positions opened: 108 | Existing positions closed: 223

Research analyst outlook

10 Wall Street Analysts provided 1 year price targets over the past 3 months

• Low target: $531 12% downside
• Avg. target: $631 4% upside
• High target: $713 18% upside

10 analyst ratings

• positive: 8 80%
• neutral: 2 20%
• negative: 0 0%

Citigroup Daniel Grosslight 79% 1-year accuracy 15 / 19 met price target	18% upside $713	Buy Maintained	13 Nov 2024
Evercore ISI Group Elizabeth Anderson 52% 1-year accuracy 17 / 33 met price target	12% upside $680	Outperform Maintained	7 Nov 2024
Baird Eric Coldwell 55% 1-year accuracy 18 / 33 met price target	13% upside $688	Outperform Upgraded	7 Nov 2024
Leerink Partners Michael Cherny 56% 1-year accuracy 18 / 32 met price target	4% upside $630	Outperform Maintained	7 Oct 2024
Deutsche Bank George Hill 100% 1-year accuracy 8 / 8 met price target	5% downside $579	Buy Maintained	25 Sept 2024